See also this year's filing and all EDGAR filings for this company.
PDF Report 0001671858_2023_ARS_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001671858, ARS Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 277,700,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 329,000 |
| 3 | remainder_Assets | 3,406,000 |
| 4 | LiabilitiesCurrent | 5,444,000 |
| 5 | LiabilitiesNoncurrent | 3,105,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,456,000 |
| 9 | ResearchAndDevelopmentExpense | 18,376,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,316,000 |
| 12 | remainder_NetIncome | 834,000 |
| 13 | remainder_ComprehensiveNetIncome | 407,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 281,435,000 |
| 1 | Liabilities | 8,549,000 |
| 2 | Expenses | 36,832,000 |
| 3 | Revenues | 1,316,000 |
| 4 | StockholdersEquity | 272,886,000 |
| 5 | NetIncome | -34,682,000 |
| 6 | ComprehensiveNetIncome | -34,478,500 |
| 7 | BaseVar | 164,686,500 |
| 8 | EconomicCapitalRatio | 3.00 |
Edgar->Model Mapping
Feature Distribution
Change over Time
